BRIEF published on 10/02/2025 at 07:05, 7 months 13 days ago Diya Lowe Appointed Head of Distribution Asia Pacific at Bellevue Asset Management Asset Management Business Development Asia Pacific Bellevue Asset Management Diya Lowe
BRIEF published on 10/02/2025 at 07:05, 7 months 13 days ago Diya Lowe nommée responsable de la distribution Asie-Pacifique chez Bellevue Asset Management Gestion D'actifs Asie-Pacifique Développement Des Affaires Bellevue Asset Management Diya Lowe
BRIEF published on 10/02/2025 at 07:05, 7 months 13 days ago Newron Pharmaceuticals Highlights Evenamide at ECNP Congress 2025 Clinical Trial Schizophrenia Newron Pharmaceuticals Evenamide ECNP Congress
BRIEF published on 10/02/2025 at 07:05, 7 months 13 days ago Newron Pharmaceuticals présente l'Evenamide au congrès ECNP 2025 Schizophrénie Essai Clinique Newron Pharmaceuticals Evenamide Congrès De L'ECNP
BRIEF published on 10/02/2025 at 07:05, 7 months 13 days ago CRYPTO BLOCKCHAIN INDUSTRIES : Performances solides en septembre 2025 Bitcoin Crypto-actifs CBI Stratégie ACE Blockware Solutions
BRIEF published on 10/02/2025 at 07:05, 7 months 13 days ago CRYPTO BLOCKCHAIN INDUSTRIES: Solid performance in September 2025 Bitcoin Crypto-assets CBI ACE Strategy Blockware Solutions
BRIEF published on 10/02/2025 at 07:04, 7 months 13 days ago Grenke AG Reports EUR 2.4 Billion in New Business for 2025 GRENKE AG Contribution Margin Leasing Growth Region Performance Factoring Decline
BRIEF published on 10/02/2025 at 07:04, 7 months 13 days ago Grenke AG annonce 2,4 milliards d'euros de nouvelles activités pour 2025 GRENKE AG Performances Régionales Marge De Contribution Croissance Du Crédit-bail Déclin De L'affacturage
BRIEF published on 10/02/2025 at 06:35, 7 months 13 days ago Formycon Secures U.S. License for Aflibercept Biosimilar Formycon AG U.S. Market Launch Aflibercept Biosimilar Regeneron Agreement Patent Dispute Resolution
BRIEF published on 10/02/2025 at 06:35, 7 months 13 days ago Formycon obtient une licence américaine pour le biosimilaire d'Aflibercept Formycon AG Lancement Sur Le Marché Américain Biosimilaire D'Aflibercept Accord Regeneron Résolution Des Litiges En Matière De Brevets
Published on 05/16/2026 at 01:15, 2 hours 4 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 3 hours 19 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 4 hours 9 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 4 hours 19 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 7 hours 9 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 9 hours 9 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 9 hours 46 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 12 hours 11 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 12 hours 19 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 17 hours 9 minutes ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 18 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 9 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
